Ironwood Pharmaceuticals Falls 6% Following Disappointing Phase 2a Study

By: via Benzinga
Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) fell more than 6 percent early Tuesday morning after the company announced ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.